Laura Longo
Catania, 95123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational Study.
Journal: Journal of clinical medicine
Published: July 08, 2025
Extramedullary Acute Myeloid Leukemia: Evaluating Azacitidine-Venetoclax Combination Outcomes and the Role of Molecular Genetics and Bone Marrow Involvement.
Journal: European journal of haematology
Published: June 24, 2025
Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax.
Journal: Journal of clinical medicine
Published: June 02, 2025
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease.
Journal: Journal of clinical medicine
Published: June 22, 2024
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data.
Journal: Healthcare (Basel, Switzerland)
Published: April 23, 2023
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries.
Journal: Frontiers in pharmacology
Published: February 19, 2023
Pegylated Asparaginase-Induced Liver Injury: A Case-Based Review and Data From Pharmacovigilance.
Journal: Journal of clinical pharmacology
Published: January 19, 2022
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries.
Journal: Frontiers in pharmacology
Published: November 26, 2021
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?
Journal: Cancers
Published: October 19, 2021
Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries.
Journal: Frontiers in pharmacology
Published: August 07, 2021
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database.
Journal: Frontiers in pharmacology
Published: July 28, 2021
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
Journal: Frontiers in immunology
Published: January 31, 2021
Last Updated: 09/26/2026